Semble’s platform has now crossed the milestone of more than 10 million patients, serving over 1,700 healthcare organizations and supporting more than 16,000 healthcare professionals across 80 specialities in the UK and France .

The problem of fragmented healthcare technology

Outpatient providers in the UK and Europe often rely on a patchwork of separate software tools for electronic health records (EHR), telehealth, scheduling, payments, and analytics. This fragmentation creates operational complexity for clinicians and a disjointed experience for patients .

Semble addresses this by offering an integrated system designed to act as an AI-powered care orchestration layer. The platform connects every stage of the outpatient journey, from booking to billing, and integrates with over 1,200 external tools—including labs, pharmacies, AI scribes, CRMs, and billing systems—to automate administrative work and improve data exchange .

From fragmented point solutions to orchestrated care

Christoph Lippuner, CEO and co-founder of Semble, framed the funding as a response to a systemic industry failure.

“For years, the industry has tried to address complex systemic issues through disconnected point solutions, but fragmented technology often adds operational complexity for healthcare providers and creates an interrupted experience for patients,” he said. “What healthcare organisations need is intelligent orchestration across the entire care journey. The practices and groups that win over the next decade will be the ones that deliver the best patient experience end-to-end. This investment allows us to rapidly scale that vision across the UK and Europe.”

The company’s client list already includes major private providers such as Nuffield Health, Welbeck, Midland Health, London Doctors Clinic, Modality, and ProblemShared .

How Semble plans to use the £30 million

The Series C capital will be directed toward several specific goals :

• Expand into the largest healthcare groups in the UK. Semble intends to move deeper into enterprise-scale providers.
• Advance its position as the AI orchestration layer for modern care delivery. The company will invest in its AI and automation features to make the platform more proactive and predictive.
• Strengthen its presence in France. The platform has already demonstrated regulatory maturity in the French market, and the new funding will accelerate that foothold.
• Scale headcount and grow its integrations ecosystem. To support the wider rollout, Semble plans to hire across engineering, commercial, and customer success teams while continuing to build out its library of third-party integrations.
• Rapidly scale a vision of connected, intelligent care across the UK and Europe. The broader ambition is to become the foundational infrastructure layer for outpatient healthcare on the continent.

Semble’s trajectory reflects a broader shift in healthtech away from building new point solutions and toward consolidating and orchestrating existing ones. The company’s latest funding round signals investor confidence that an integrated, AI-powered operating system for private outpatient care can win in a market long frustrated by fragmentation.

Semble’s platform has now crossed the milestone of more than 10 million patients, serving over 1,700 healthcare organizations and supporting more than 16,000 healthcare professionals across 80 specialities in the UK and France .

The problem of fragmented healthcare technology

Outpatient providers in the UK and Europe often rely on a patchwork of separate software tools for electronic health records (EHR), telehealth, scheduling, payments, and analytics. This fragmentation creates operational complexity for clinicians and a disjointed experience for patients .

Semble addresses this by offering an integrated system designed to act as an AI-powered care orchestration layer. The platform connects every stage of the outpatient journey, from booking to billing, and integrates with over 1,200 external tools—including labs, pharmacies, AI scribes, CRMs, and billing systems—to automate administrative work and improve data exchange .

From fragmented point solutions to orchestrated care

Christoph Lippuner, CEO and co-founder of Semble, framed the funding as a response to a systemic industry failure.

“For years, the industry has tried to address complex systemic issues through disconnected point solutions, but fragmented technology often adds operational complexity for healthcare providers and creates an interrupted experience for patients,” he said. “What healthcare organisations need is intelligent orchestration across the entire care journey. The practices and groups that win over the next decade will be the ones that deliver the best patient experience end-to-end. This investment allows us to rapidly scale that vision across the UK and Europe.”

The company’s client list already includes major private providers such as Nuffield Health, Welbeck, Midland Health, London Doctors Clinic, Modality, and ProblemShared .

How Semble plans to use the £30 million

The Series C capital will be directed toward several specific goals :

• Expand into the largest healthcare groups in the UK. Semble intends to move deeper into enterprise-scale providers.
• Advance its position as the AI orchestration layer for modern care delivery. The company will invest in its AI and automation features to make the platform more proactive and predictive.
• Strengthen its presence in France. The platform has already demonstrated regulatory maturity in the French market, and the new funding will accelerate that foothold.
• Scale headcount and grow its integrations ecosystem. To support the wider rollout, Semble plans to hire across engineering, commercial, and customer success teams while continuing to build out its library of third-party integrations.
• Rapidly scale a vision of connected, intelligent care across the UK and Europe. The broader ambition is to become the foundational infrastructure layer for outpatient healthcare on the continent.

Semble’s trajectory reflects a broader shift in healthtech away from building new point solutions and toward consolidating and orchestrating existing ones. The company’s latest funding round signals investor confidence that an integrated, AI-powered operating system for private outpatient care can win in a market long frustrated by fragmentation.